Toxic Hepatitis with Isoniazid and Rifampin-Reference-Cited by-同舟云学术

Toxic Hepatitis with Isoniazid and Rifampin

Published:1991-02 Issue:2 Volume:99 Page:465-471
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Steele Malcolm A.,Burk Raymond F.,DesPrez Roger M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference77 articles.

1. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin;Sarma;Am Rev Respir Dis,1986

2. Toxic hepatitis with jaundice occurring in a patient treated with isoniazid;Randolph;JAMA,1953

3. Fatal hepatic necrosis secondary to isoniazid therapy;Cohen;JAMA,1961

4. Isoniazid-induced liver disease;Maddrey;Seminars in Liver Disease,1981

5. Controlled chemoprophylaxis trials in tuberculosis. A general review;Ferebee;Bibl Tuberc,1970

Cited by 382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

2. HLA-DPB1*05:01 and HLA-A*11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea;Journal of Clinical Medicine;2024-06-18

3. Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis;Scientific Reports;2024-05-28

4. Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis;Clinical Infectious Diseases;2024-03-11

5. Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients;Infection;2024-02-13